Grebennikov Vladimir MD Richardson, TX - 75080

Grebennikov Vladimir MD is categorized under Internal Medicine Doctors in Richardson, TX and active since 2007.

Grebennikov Vladimir MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Vladimir Grebennikov at the company’s single location by writing to 870 North Coit Road # 2660, Richardson, Texas TX 75080 or by phoning (972) 690-4996. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Grebennikov Vladimir MD
Contact Person: Vladimir Grebennikov
Address: 870 North Coit Road # 2660, Richardson, Texas 75080
Phone Number: (972) 690-4996
Annual Revenue (USD): $500.000 to $999.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Grebennikov Vladimir MD was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Vladimir Grebennikov for inquiries that concern Grebennikov Vladimir MD by calling the company number (972) 690-4996, as your correspondence is most welcome. Additionally, the physical location of the single location of Grebennikov Vladimir MD can be found at the coordinates 32.95775,-96.76842 as well as the street address 870 North Coit Road # 2660 in Richardson, Texas 75080.

For its online presence, you may visit Grebennikov Vladimir MD’s website at and engage with its social media outlets through on Twitter and on Facebook.